GlucoTrack Inc GCTK 深 滬
已收盤 02-06 16:00:00 美东时间
1.74
+0.190
+12.26%
華盛通- 最 高1.77
- 今 開1.53
- 成交量 15.32万股
- 最 低 1.5232
- 昨 收 1.55
- 總市值 158.46万
- 52周最高 30.51
- 市盈率 靜 --
- 換手率 16.82%
- 52周最低 1.5232
- 委 比 -87.97%
- 總股本 91.07万
- 歷史最高 29100.00
- 量 比 0.67
- 振 幅 15.92%
- 歷史最低 1.5232
- 每 手 1
- 風險率 6.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多The US Patent and Trademark Office has issued Patents For Glucotrack's Continuous Blood Glucose Monitoring Platform
The patents strengthen Glucotrack's competitive position and intellectual property protection as the Company advances its multi-year, fully implantable CBGM system toward commercialization.The three patents protect key
01-29 21:06
GlucoTrack Secures USPTO Patents for Fully Implantable Continuous Blood Glucose Monitoring System
GlucoTrack Secures USPTO Patents for Fully Implantable Continuous Blood Glucose Monitoring System GlucoTrack Inc. announced that the US Patent and Trademark Office has issued three patents for its continuous blood glucose monitoring (CBGM) platform. The patents, US 12,453,494, US 12,458,257, and US
01-29 21:02
Glucotrack Raises About $4M in Stock Deal of 1.03M Shares Priced at $3.87 Per Share
Glucotrack, Inc. (NASDAQ:GCTK) (the "Company"), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it has entered
2025-12-30 21:04
GlucoTrack Issues Investor Presentation Under Regulation FD
The latest announcement is out from GlucoTrack ( ($GCTK) ). On December 29, 202...
2025-12-29 21:27
GlucoTrack Q3 EPS $(4.64) Up From $(1.09 thousand) YoY
GlucoTrack (NASDAQ:GCTK) reported quarterly losses of $(4.64) per share. This is a 99.58 percent increase over losses of $(1.09 thousand) per share from the same period last year.
2025-11-14 05:31
GlucoTrack Appoints Dr. Usman Latif to Advisory Team
The latest announcement is out from GlucoTrack ( ($GCTK) ). On October 29, 2025...
2025-10-30 04:59
Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team
Glucotrack, Inc., a medical device company focused on diabetes technologies, has announced the addition of Dr. Usman Latif to its clinical advisory team. Dr. Latif, a leading pain management specialist with expertise in neuromodulation and treatment of Painful Diabetic Neuropathy (PDN), will provide strategic counsel as the Company advances its integrated glucose monitoring solutions. Glucotrack aims to integrate its glucose sensing technology in...
2025-10-29 20:05
Glucotrack, Inc. Reminds Shareholders to Vote
Glucotrack, Inc. will hold a Special Meeting of Shareholders on October 31, 2025, at 12 p.m. ET, to vote on an Equity Purchase Agreement with Sixth Borough Capital Fund. Shareholders of record as of September 23, 2025, are eligible to vote and are encouraged to do so quickly via telephone, online, or by proxy. The Board of Directors recommends voting “FOR” all proposals. Detailed information is available in the Company’s proxy statement filed wit...
2025-10-28 12:00
GlucoTrack Secures $3.6M Convertible Promissory Note
GlucoTrack ( ($GCTK) ) just unveiled an announcement. On September 12, 2025, Gl...
2025-09-13 05:49
美股异动 | 出售最高2000万美元普通股 GlucoTrack(GCTK.US)飙升超123%
周五，GlucoTrack(GCTK.US)飙升超123%，报10.91美元。
2025-09-12 23:29
